AnalystsLaura Prendergast
Laura Prendergast's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 12%
#585 out of 5254 analysts
Average Return
+94.25%
Win Rate
47%9 out of 19
Risk vs Reward
Poor
Good

Laura Prendergast's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Erasca IncERAS
+980.41%$1.48$15.99
2025-03-26 -
2026-03-25
Buy
Erasca IncERAS
+651.38%$2.53$19.01
2025-10-16 -
2026-04-17
Strong Buy
Revolution Medicines IncRVMD
+199.17%$49.68$148.63
2025-10-16 -
2026-04-17
Strong Buy
Tango Therapeutics IncTNGX
+169.09%$9.90$26.64
2025-12-04 -
2026-04-17
Strong Buy
Tango Therapeutics IncTNGX
+61.95%$16.45$26.64
2026-03-09 -
2026-04-17
Strong Buy

Laura Prendergast's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Tango Therapeutics IncTNGX
2Strong Buy$24.00-9.91%Maintains
a month ago
Olema Pharmaceuticals IncOLMA
1Strong Buy$48.00+185.37%Initiates Coverage On
2 months ago
Bridgebio Oncology Therapeutics IncBBOT
1Strong Buy$23.00+145.99%Initiates Coverage On
2 months ago
Revolution Medicines IncRVMD
4Strong Buy$170.00+14.38%Maintains
3 months ago
Foghorn Therapeutics IncFHTX
1Strong Buy$12.00+126.84%Initiates Coverage On
5 months ago
Nuvalent IncNUVL
2Strong Buy$135.00+25.45%Maintains
5 months ago
Black Diamond Therapeutics IncBDTX
2Strong Buy$8.00+161.44%Reinstates
6 months ago
Erasca IncERAS
2Strong Buy$4.00-78.96%Initiates Coverage On
6 months ago
Cogent Biosciences IncCOGT
1Hold$16.00-57.05%Initiates Coverage On
6 months ago
Mural Oncology PLCMURA
1Strong Buy$18.00N/AInitiates Coverage On
2 years ago
Nkarta IncNKTX
2Strong Buy$16.00N/AUpgrades
2 years ago
Third Harmonic Bio IncTHRD
1Buy$18.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.